Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Clemons

Showing results (41-50 of 267) with videos related to

Pageof 27
Sort By:
Journal of Oncology Practice|August 7, 2014
Surviving SurveysSasha Mazzarello, Mark Clemons, Ian D Graham, et al.
Journal of Bone Oncology|February 25, 2016
Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?Kent Russell, Mark Clemons, Luis Costa, et al.
Current Opinion in Supportive and Palliative Care|November 26, 2013
Definition and consequences of locally advanced breast cancerDemetrios Simos, Mark Clemons, Ophira M Ginsburg, et al.
Breast Cancer Research and Treatment|May 8, 2012
Adjuvant bisphosphonate treatment for breast cancer: why did something so elegant become so complicated?Mark Clemons, Kent Russell, Luis Costa, et al.
Breast Cancer Research and Treatment|December 2, 2005
Can bone markers guide more effective treatment of bone metastases from breast cancer?Mark Clemons, David E C Cole, Mary C Gainford
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2014
Aprepitant versus dexamethasone to prevent delayed emesis after chemotherapyTerry L Ng, Mark Clemons, Brian Hutton, et al.
Journal of Bone Oncology|November 19, 2015
Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meetingCarmel Jacobs, Eitan Amir, Alexander Paterson, et al.
Cancer Treatment Reviews|January 27, 2010
Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancerEitan Amir, Alberto Ocaña, Bostjan Seruga, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|July 7, 2012
Travelling on parallel tracks: patient and physician perspectives on why women delay seeking care for breast cancer symptomsLeeat Granek, Barbara Fitzgerald, Karen Fergus, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|April 8, 2010
Why women delay seeking assistance for locally advanced breast cancerJudy Gould, Barbara Fitzgerald, Karen Fergus, et al.
Pageof 27

Showing results (41-50 of 267) with videos related to

Sort By:
Pageof 27
Journal of Oncology Practice|August 7, 2014
Surviving SurveysSasha Mazzarello, Mark Clemons, Ian D Graham, et al.
Journal of Bone Oncology|February 25, 2016
Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?Kent Russell, Mark Clemons, Luis Costa, et al.
Current Opinion in Supportive and Palliative Care|November 26, 2013
Definition and consequences of locally advanced breast cancerDemetrios Simos, Mark Clemons, Ophira M Ginsburg, et al.
Breast Cancer Research and Treatment|May 8, 2012
Adjuvant bisphosphonate treatment for breast cancer: why did something so elegant become so complicated?Mark Clemons, Kent Russell, Luis Costa, et al.
Breast Cancer Research and Treatment|December 2, 2005
Can bone markers guide more effective treatment of bone metastases from breast cancer?Mark Clemons, David E C Cole, Mary C Gainford
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2014
Aprepitant versus dexamethasone to prevent delayed emesis after chemotherapyTerry L Ng, Mark Clemons, Brian Hutton, et al.
Journal of Bone Oncology|November 19, 2015
Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meetingCarmel Jacobs, Eitan Amir, Alexander Paterson, et al.
Cancer Treatment Reviews|January 27, 2010
Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancerEitan Amir, Alberto Ocaña, Bostjan Seruga, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|July 7, 2012
Travelling on parallel tracks: patient and physician perspectives on why women delay seeking care for breast cancer symptomsLeeat Granek, Barbara Fitzgerald, Karen Fergus, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|April 8, 2010
Why women delay seeking assistance for locally advanced breast cancerJudy Gould, Barbara Fitzgerald, Karen Fergus, et al.
Pageof 27